A More Pleasant Way
to Screen for Colon Cancer


Our Shield™ blood test is now FDA-approved for use in adults age 45 and older who are at average risk of colorectal cancer.

Male doctor and female patient discuss.

Screening for Early
Signs of Cancer

Our Shield blood test offers individuals a more pleasant and convenient screening option that helps overcome barriers associated with available methods, including colonoscopy and stool-based testing, which can be unpleasant, time-consuming and difficult to complete.

Closing the Gap

Cancer screening is a proven way to detect cancer early, when it’s most treatable. However, 1 in 3 eligible Americans do not complete colorectal cancer screening in part because they find the current options unpleasant or inconvenient.1

Blood-based screening tests like Shield that can be completed as part of a simple blood draw have the potential to improve screening adherence and identify more cancers early, when they are most treatable.

Our ECLIPSE study validates Shield as a high-sensitivity blood test for colorectal cancer screening.
Explore Our Cancer Screening Studies

Learn More About Shield

Interested in learning more about our Shield blood test for early cancer screening?

Visit ShieldCancerScreen.com